Safety and efficacy of drug-eluting and bare metal stents: Comprehensive meta-analysis of randomized trials and observational studies

Circulation

Volumn 119, Issue 25, 2009, Pages 3198-3206

  Kirtane, Ajay J ^a   Gupta, Anuj ^a   Iyengar, Srinivas ^a   Moses, Jeffrey W ^a   Leon, Martin B ^a   Applegate, Robert ^b   Brodie, Bruce ^c   Hannan, Edward ^d   Harjai, Kishore ^e   Jensen, Lisette Okkels ^f   Park, Seung Jung ^g   Perry, Raphael ^h   Racz, Michael ⁱ   Saia, Francesco ^j   Tu, Jack V ^k   Waksman, Ron ^l   Lansky, Alexandra J ^a   Mehran, Roxana ^a   Stone, Gregg W ^a  

^a NewYork Presbyterian Hospital   (United States)

^b WAKE FOREST BAPTIST HEALTH   (United States)

^c MOSES H CONE MEMORIAL HOSPITAL   (United States)

^d STATE UNIVERSITY OF NEW YORK   (United States)

^e GUTHRIE RESEARCH INSTITUTE   (United States)

^f ODENSE UNIVERSITY HOSPITAL   (Denmark)

^g Asan Medical Center   (South Korea)

^h LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

ⁱ NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^j UNIVERSITY OF BOLOGNA   (Italy)

^k INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^l WASHINGTON HOSPITAL CENTER   (United States)

more..

Author keywords

Angioplasty; Coronary disease; Meta analysis; Registries; Stents

Indexed keywords

ARTICLE; BARE METAL STENT; CLINICAL TRIAL; CONTROLLED STUDY; DRUG ELUTING STENT; FOLLOW UP; HAZARD RATIO; HEART DEATH; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; MORTALITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; REVASCULARIZATION; SYSTEMATIC REVIEW; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; RANDOMIZED CONTROLLED TRIAL; REGISTER; SAFETY; TRANSLUMINAL CORONARY ANGIOPLASTY;

METAL;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; HUMANS; METALS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGISTRIES; SAFETY;

EID: 67650755016     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.826479     Document Type: Article

References (16)

1. Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice M-C, Colombo A, Schampaert E, Grube E, Kirtane AJ, Cutlip DE, Fahy M, Pocock SJ, Mehran R, Leon MB. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med. 2007;356:998-1008.
2. US Food and Drug Administration. Update to FDA Statement on Coronary Drug-Eluting Stents. Available at: http://www.fda.gov/cdrh/news/010407.html. Accessed June 10, 2008.
3. King SB III, Smith SC Jr, Hirshfeld JW Jr, Jacobs AK, Morrison DA, Williams DO, Feldman TE, Kern MJ, O'Neill WW, Schaff HV, Whitlow PL, for the ACC/AHA/SCAI, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Page RL, Riegel B, Tarkington LG, Yancy CW. 2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention. J Am Coll Cardiol. 2008;51:172-209.
4. Stone GW, Ellis SG, Colombo A, Dawkins KD, Grube E, Cutlip DE, Friedman M, Baim DS, Koglin J. Offsetting impact of thrombosis and restenosis on the occurrence of death and myocardial infarction after paclitaxel-eluting and bare metal stent implantation. Circulation. 2007; 115:2842-2847.
5. Jeremias A, Kirtane A. Balancing efficacy and safety of drug-eluting stents in patients undergoing percutaneous coronary intervention. Ann Intern Med. 2008;148:234-238.
6. Win HK, Caldera AE, Maresh K, Lopez J, Rihal CS, Parikh MA, Granada JF, Marulkar S, Nassif D, Cohen DJ, Kleiman NS. Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents. JAMA. 2007;297:2001-2009.
7. Marroquin OC, Selzer F, Mulukutla SR, Williams DO, Vlachos HA, Wilensky RL, Tanguay JF, Holper EM, Abbott JD, Lee JS, Smith C, Anderson WD, Kelsey SF, Kip KE. A comparison of bare-metal and drug-eluting stents for off-label indications. N Engl J Med. 2008;358: 342-352.
8. Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, Kukreja N, Juni P, Sianos G, Hellige G, van Domburg RT, Hess OM, Boersma E, Meier B, Windecker S, Serruys PW. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet. 2007;369:667-678.
9. Hannan EL. Randomized clinical trials and observational studies: guidelines for assessing respective strengths and limitations. J Am Coll Cardiol Intv. 2008;1:211-217.
10. Cleophas TJ, Zwinderman AH. Meta-analysis. Circulation. 2007;115: 2870-2875.
11. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-188.
12. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-560.
13. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088-1101.
14. Bhatt DL, Flather MD, Hacke W, Berger PB, Black HR, Boden WE, Cacoub P, Cohen EA, Creager MA, Easton JD, Hamm CW, Hankey GJ, Johnston SC, Mak K-H, Mas J-L, Montalescot G, Pearson TA, Steg PG, Steinhubl SR, Weber MA, Fabry-Ribaudo L, Hu T, Topol EJ, Fox KAA. Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. J Am Coll Cardiol. 2007; 49:1982-1988.
15. Garg P, Cohen DJ, Gaziano T, Mauri L. Balancing the risks of restenosis and stent thrombosis in bare-metal versus drug-eluting stents: results of a decision analytic model. J Am Coll Cardiol. 2008;51:1844-1853.
16. Doyle B, Rihal CS, O'Sullivan CJ, Lennon RJ, Wiste HJ, Bell M, Bresnahan J, Holmes DR, Jr. Outcomes of stent thrombosis and restenosis during extended follow-up of patients treated with bare-metal coronary stents. Circulation. 2007;116:2391-2398.